pyrroles has been researched along with Adult Periodontitis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aykaç, Y; Fentoğlu, O; Gürgan, CA; Kale, B; Kirzioğlu, FY; Oz, SG; Sönmez, Y; Sözen, T; Tonguç, MO | 1 |
Espinosa-Chávez, EJ; Fajardo, ME; Rocha, ML; Sánchez-Marin, FJ | 1 |
Ay, ZY; Fentoğlu, Ö; Hiçyılmaz, H; Kırzıoğlu, FY; Köroğlu, BK; Orhan, H; Özdem, M; Öztürk Tonguç, M; Sert, T; Sütçü, R; Tamer, MN | 1 |
Narula, SC; Sangwan, A; Sharma, RK; Singh, H; Tewari, S | 1 |
Kumari, M; Martande, SS; Naik, SB; Pradeep, AR; Rao, NS | 1 |
Tanaka, E; Watanabe, T; Yasue, A | 1 |
2 trial(s) available for pyrroles and Adult Periodontitis
Article | Year |
---|---|
Effect of atorvastatin on chronic periodontitis: a randomized pilot study.
Topics: Adult; Alveolar Bone Loss; Anticholesteremic Agents; Atorvastatin; Chronic Periodontitis; Dental Plaque; Dental Scaling; Double-Blind Method; Female; Gingival Recession; Heptanoic Acids; Humans; Lipids; Male; Middle Aged; Pilot Projects; Pyrroles; Radiography, Dental, Digital; Statistics, Nonparametric; Tooth Mobility | 2010 |
Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial.
Topics: Administration, Topical; Adult; Alveolar Bone Loss; Atorvastatin; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque Index; Dental Scaling; Female; Follow-Up Studies; Gels; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteogenesis; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Pyrroles; Root Planing; Treatment Outcome | 2013 |
4 other study(ies) available for pyrroles and Adult Periodontitis
Article | Year |
---|---|
Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Chronic Periodontitis; Dental Plaque Index; Dental Scaling; Female; Follow-Up Studies; Gingival Hemorrhage; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Oral Hygiene; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Pyrroles; Root Planing; Treatment Outcome; Triglycerides | 2010 |
Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia.
Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Atorvastatin; Body Mass Index; Chronic Periodontitis; Cytokines; Female; Gingival Crevicular Fluid; Gingivitis; Heptanoic Acids; Humans; Hyperlipidemias; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Lipid Mobilization; Lipids; Male; Middle Aged; Periodontal Index; Pyrroles; Reproducibility of Results; Statistics, Nonparametric; Tumor Necrosis Factor-alpha | 2011 |
Periodontal status and hyperlipidemia: statin users versus non-users.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chronic Periodontitis; Cross-Sectional Studies; Dental Plaque Index; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontium; Pyrroles; Single-Blind Method; Triglycerides | 2013 |
Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Topics: Adolescent; Cell Culture Techniques; Cells, Cultured; Chronic Periodontitis; Cycloheximide; Dose-Response Relationship, Drug; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Male; Periodontal Ligament; Phosphorylation; Protein Synthesis Inhibitors; Pyridines; Pyrroles; Signal Transduction; Smad3 Protein; Time Factors; Transforming Growth Factor beta1 | 2013 |